nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP1A2—type 2 diabetes mellitus	0.106	0.602	CbGaD
Valproic Acid—CYP3A4—type 2 diabetes mellitus	0.0704	0.398	CbGaD
Valproic Acid—UGT1A10—Losartan—type 2 diabetes mellitus	0.0559	0.108	CbGbCtD
Valproic Acid—SLC16A1—Nateglinide—type 2 diabetes mellitus	0.0397	0.0764	CbGbCtD
Valproic Acid—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0286	0.0551	CbGbCtD
Valproic Acid—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0268	0.0516	CbGbCtD
Valproic Acid—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0228	0.0439	CbGbCtD
Valproic Acid—UGT1A3—Losartan—type 2 diabetes mellitus	0.0184	0.0355	CbGbCtD
Valproic Acid—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0135	0.026	CbGbCtD
Valproic Acid—UGT2B7—Losartan—type 2 diabetes mellitus	0.0133	0.0257	CbGbCtD
Valproic Acid—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0132	0.0254	CbGbCtD
Valproic Acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0125	0.024	CbGbCtD
Valproic Acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0125	0.024	CbGbCtD
Valproic Acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0115	0.0222	CbGbCtD
Valproic Acid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.011	0.0211	CbGbCtD
Valproic Acid—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00997	0.0192	CbGbCtD
Valproic Acid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.00976	0.0188	CbGbCtD
Valproic Acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00947	0.0182	CbGbCtD
Valproic Acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00908	0.0175	CbGbCtD
Valproic Acid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0083	0.016	CbGbCtD
Valproic Acid—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00797	0.0153	CbGbCtD
Valproic Acid—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00721	0.0139	CbGbCtD
Valproic Acid—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00711	0.0137	CbGbCtD
Valproic Acid—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00695	0.0134	CbGbCtD
Valproic Acid—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00665	0.0128	CbGbCtD
Valproic Acid—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00643	0.0124	CbGbCtD
Valproic Acid—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00636	0.0122	CbGbCtD
Valproic Acid—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00605	0.0116	CbGbCtD
Valproic Acid—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00605	0.0116	CbGbCtD
Valproic Acid—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00591	0.0114	CbGbCtD
Valproic Acid—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00568	0.0109	CbGbCtD
Valproic Acid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00561	0.0108	CbGbCtD
Valproic Acid—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00558	0.0107	CbGbCtD
Valproic Acid—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00539	0.0104	CbGbCtD
Valproic Acid—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00524	0.0101	CbGbCtD
Valproic Acid—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00515	0.00991	CbGbCtD
Valproic Acid—SLC22A6—Losartan—type 2 diabetes mellitus	0.00513	0.00987	CbGbCtD
Valproic Acid—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00503	0.00968	CbGbCtD
Valproic Acid—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00503	0.00968	CbGbCtD
Valproic Acid—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00464	0.00893	CbGbCtD
Valproic Acid—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00454	0.00873	CbGbCtD
Valproic Acid—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00448	0.00863	CbGbCtD
Valproic Acid—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0041	0.00789	CbGbCtD
Valproic Acid—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00405	0.00781	CbGbCtD
Valproic Acid—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00404	0.00778	CbGbCtD
Valproic Acid—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00383	0.00738	CbGbCtD
Valproic Acid—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00381	0.00734	CbGbCtD
Valproic Acid—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0037	0.00712	CbGbCtD
Valproic Acid—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00365	0.00703	CbGbCtD
Valproic Acid—CYP3A5—Losartan—type 2 diabetes mellitus	0.00351	0.00676	CbGbCtD
Valproic Acid—CYP2C8—Losartan—type 2 diabetes mellitus	0.00338	0.0065	CbGbCtD
Valproic Acid—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00323	0.00622	CbGbCtD
Valproic Acid—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0031	0.00596	CbGbCtD
Valproic Acid—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00292	0.00563	CbGbCtD
Valproic Acid—CYP2C19—Losartan—type 2 diabetes mellitus	0.00283	0.00545	CbGbCtD
Valproic Acid—CYP1A2—Losartan—type 2 diabetes mellitus	0.00261	0.00503	CbGbCtD
Valproic Acid—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00257	0.00496	CbGbCtD
Valproic Acid—CYP2C9—Losartan—type 2 diabetes mellitus	0.00235	0.00453	CbGbCtD
Valproic Acid—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00222	0.00427	CbGbCtD
Valproic Acid—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00212	0.00409	CbGbCtD
Valproic Acid—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00212	0.00409	CbGbCtD
Valproic Acid—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00387	CbGbCtD
Valproic Acid—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0015	0.00288	CbGbCtD
Valproic Acid—CYP3A4—Losartan—type 2 diabetes mellitus	0.00137	0.00264	CbGbCtD
Valproic Acid—OGDH—islet of Langerhans—type 2 diabetes mellitus	0.00125	0.025	CbGeAlD
Valproic Acid—UGT1A10—kidney—type 2 diabetes mellitus	0.0012	0.024	CbGeAlD
Valproic Acid—UGT2B15—islet of Langerhans—type 2 diabetes mellitus	0.00112	0.0225	CbGeAlD
Valproic Acid—HDAC9—islet of Langerhans—type 2 diabetes mellitus	0.0011	0.022	CbGeAlD
Valproic Acid—OGDH—retina—type 2 diabetes mellitus	0.00107	0.0214	CbGeAlD
Valproic Acid—OGDH—nephron tubule—type 2 diabetes mellitus	0.001	0.0201	CbGeAlD
Valproic Acid—UGT1A8—kidney—type 2 diabetes mellitus	0.000949	0.019	CbGeAlD
Valproic Acid—OGDH—cardiovascular system—type 2 diabetes mellitus	0.000902	0.0181	CbGeAlD
Valproic Acid—HDAC9—nephron tubule—type 2 diabetes mellitus	0.000885	0.0177	CbGeAlD
Valproic Acid—OGDH—kidney—type 2 diabetes mellitus	0.000882	0.0177	CbGeAlD
Valproic Acid—OGDH—pancreas—type 2 diabetes mellitus	0.000877	0.0176	CbGeAlD
Valproic Acid—OGDH—cortex of kidney—type 2 diabetes mellitus	0.000859	0.0172	CbGeAlD
Valproic Acid—ACADSB—nephron tubule—type 2 diabetes mellitus	0.000798	0.016	CbGeAlD
Valproic Acid—OGDH—adipose tissue—type 2 diabetes mellitus	0.000795	0.0159	CbGeAlD
Valproic Acid—HDAC9—cardiovascular system—type 2 diabetes mellitus	0.000795	0.0159	CbGeAlD
Valproic Acid—UGT2B15—pancreas—type 2 diabetes mellitus	0.00079	0.0158	CbGeAlD
Valproic Acid—HDAC9—pancreas—type 2 diabetes mellitus	0.000773	0.0155	CbGeAlD
Valproic Acid—UGT1A10—liver—type 2 diabetes mellitus	0.000759	0.0152	CbGeAlD
Valproic Acid—HDAC9—cortex of kidney—type 2 diabetes mellitus	0.000758	0.0152	CbGeAlD
Valproic Acid—ABAT—islet of Langerhans—type 2 diabetes mellitus	0.000746	0.0149	CbGeAlD
Valproic Acid—UGT1A4—kidney—type 2 diabetes mellitus	0.000719	0.0144	CbGeAlD
Valproic Acid—ACADSB—cardiovascular system—type 2 diabetes mellitus	0.000717	0.0143	CbGeAlD
Valproic Acid—UGT1A6—liver—type 2 diabetes mellitus	0.000706	0.0141	CbGeAlD
Valproic Acid—ALDH5A1—nephron tubule—type 2 diabetes mellitus	0.000702	0.0141	CbGeAlD
Valproic Acid—HDAC9—adipose tissue—type 2 diabetes mellitus	0.000701	0.014	CbGeAlD
Valproic Acid—ACADSB—kidney—type 2 diabetes mellitus	0.000701	0.014	CbGeAlD
Valproic Acid—ACADSB—pancreas—type 2 diabetes mellitus	0.000696	0.0139	CbGeAlD
Valproic Acid—ACADSB—cortex of kidney—type 2 diabetes mellitus	0.000683	0.0137	CbGeAlD
Valproic Acid—ABAT—retina—type 2 diabetes mellitus	0.000638	0.0128	CbGeAlD
Valproic Acid—ACADSB—adipose tissue—type 2 diabetes mellitus	0.000632	0.0127	CbGeAlD
Valproic Acid—ALDH5A1—kidney—type 2 diabetes mellitus	0.000617	0.0124	CbGeAlD
Valproic Acid—UGT1A9—kidney—type 2 diabetes mellitus	0.000603	0.0121	CbGeAlD
Valproic Acid—ALDH5A1—cortex of kidney—type 2 diabetes mellitus	0.000601	0.012	CbGeAlD
Valproic Acid—ABAT—nephron tubule—type 2 diabetes mellitus	0.000601	0.012	CbGeAlD
Valproic Acid—UGT1A8—liver—type 2 diabetes mellitus	0.0006	0.012	CbGeAlD
Valproic Acid—HDAC2—islet of Langerhans—type 2 diabetes mellitus	0.000562	0.0113	CbGeAlD
Valproic Acid—OGDH—liver—type 2 diabetes mellitus	0.000558	0.0112	CbGeAlD
Valproic Acid—ALDH5A1—adipose tissue—type 2 diabetes mellitus	0.000556	0.0111	CbGeAlD
Valproic Acid—UGT1A3—liver—type 2 diabetes mellitus	0.000535	0.0107	CbGeAlD
Valproic Acid—ABAT—kidney—type 2 diabetes mellitus	0.000528	0.0106	CbGeAlD
Valproic Acid—ABAT—pancreas—type 2 diabetes mellitus	0.000525	0.0105	CbGeAlD
Valproic Acid—ABAT—cortex of kidney—type 2 diabetes mellitus	0.000514	0.0103	CbGeAlD
Valproic Acid—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000508	0.0102	CbGeAlD
Valproic Acid—UGT2B15—liver—type 2 diabetes mellitus	0.000503	0.0101	CbGeAlD
Valproic Acid—UGT2B7—kidney—type 2 diabetes mellitus	0.000486	0.00973	CbGeAlD
Valproic Acid—HDAC2—retina—type 2 diabetes mellitus	0.000481	0.00962	CbGeAlD
Valproic Acid—ABAT—adipose tissue—type 2 diabetes mellitus	0.000476	0.00953	CbGeAlD
Valproic Acid—PTGS1—artery—type 2 diabetes mellitus	0.000466	0.00934	CbGeAlD
Valproic Acid—SLC22A7—kidney—type 2 diabetes mellitus	0.000462	0.00926	CbGeAlD
Valproic Acid—UGT1A4—liver—type 2 diabetes mellitus	0.000455	0.00911	CbGeAlD
Valproic Acid—HDAC2—nephron tubule—type 2 diabetes mellitus	0.000453	0.00906	CbGeAlD
Valproic Acid—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.00045	0.00901	CbGeAlD
Valproic Acid—ACADSB—liver—type 2 diabetes mellitus	0.000443	0.00887	CbGeAlD
Valproic Acid—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000435	0.0087	CbGeAlD
Valproic Acid—SLC16A1—retina—type 2 diabetes mellitus	0.000427	0.00855	CbGeAlD
Valproic Acid—HDAC2—cardiovascular system—type 2 diabetes mellitus	0.000407	0.00814	CbGeAlD
Valproic Acid—HDAC2—kidney—type 2 diabetes mellitus	0.000398	0.00796	CbGeAlD
Valproic Acid—HDAC2—pancreas—type 2 diabetes mellitus	0.000395	0.00791	CbGeAlD
Valproic Acid—PTGS1—endothelium—type 2 diabetes mellitus	0.000394	0.00789	CbGeAlD
Valproic Acid—ALDH5A1—liver—type 2 diabetes mellitus	0.00039	0.00781	CbGeAlD
Valproic Acid—HDAC2—cortex of kidney—type 2 diabetes mellitus	0.000387	0.00776	CbGeAlD
Valproic Acid—UGT1A9—liver—type 2 diabetes mellitus	0.000381	0.00763	CbGeAlD
Valproic Acid—SLC16A1—cardiovascular system—type 2 diabetes mellitus	0.000361	0.00723	CbGeAlD
Valproic Acid—HDAC2—adipose tissue—type 2 diabetes mellitus	0.000358	0.00718	CbGeAlD
Valproic Acid—SLC16A1—kidney—type 2 diabetes mellitus	0.000353	0.00708	CbGeAlD
Valproic Acid—ABAT—liver—type 2 diabetes mellitus	0.000334	0.00668	CbGeAlD
Valproic Acid—CYP2C18—liver—type 2 diabetes mellitus	0.000333	0.00667	CbGeAlD
Valproic Acid—SLC16A1—adipose tissue—type 2 diabetes mellitus	0.000319	0.00638	CbGeAlD
Valproic Acid—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000314	0.00629	CbGeAlD
Valproic Acid—UGT2B7—liver—type 2 diabetes mellitus	0.000307	0.00615	CbGeAlD
Valproic Acid—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000304	0.00609	CbGeAlD
Valproic Acid—SLC22A7—liver—type 2 diabetes mellitus	0.000292	0.00585	CbGeAlD
Valproic Acid—SLC22A8—kidney—type 2 diabetes mellitus	0.000267	0.00535	CbGeAlD
Valproic Acid—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.00026	0.00521	CbGeAlD
Valproic Acid—HDAC2—liver—type 2 diabetes mellitus	0.000251	0.00503	CbGeAlD
Valproic Acid—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000249	0.00499	CbGeAlD
Valproic Acid—SLC22A5—retina—type 2 diabetes mellitus	0.000244	0.00489	CbGeAlD
Valproic Acid—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.00023	0.0046	CbGeAlD
Valproic Acid—SLC16A1—liver—type 2 diabetes mellitus	0.000223	0.00447	CbGeAlD
Valproic Acid—CYP2A6—liver—type 2 diabetes mellitus	0.00022	0.00441	CbGeAlD
Valproic Acid—SLC22A5—kidney—type 2 diabetes mellitus	0.000202	0.00404	CbGeAlD
Valproic Acid—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000201	0.00402	CbGeAlD
Valproic Acid—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.0002	0.004	CbGeAlD
Valproic Acid—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000197	0.00394	CbGeAlD
Valproic Acid—CYP2C8—kidney—type 2 diabetes mellitus	0.000195	0.00391	CbGeAlD
Valproic Acid—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000182	0.00364	CbGeAlD
Valproic Acid—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000179	0.00359	CbGeAlD
Valproic Acid—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000177	0.00355	CbGeAlD
Valproic Acid—CYP3A5—kidney—type 2 diabetes mellitus	0.000176	0.00353	CbGeAlD
Valproic Acid—CYP2B6—kidney—type 2 diabetes mellitus	0.000175	0.00351	CbGeAlD
Valproic Acid—CYP3A5—pancreas—type 2 diabetes mellitus	0.000175	0.00351	CbGeAlD
Valproic Acid—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000172	0.00344	CbGeAlD
Valproic Acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000162	0.00324	CbGeAlD
Valproic Acid—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000159	0.00318	CbGeAlD
Valproic Acid—PTGS1—kidney—type 2 diabetes mellitus	0.000159	0.00317	CbGeAlD
Valproic Acid—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000143	0.00286	CbGeAlD
Valproic Acid—CYP2C19—liver—type 2 diabetes mellitus	0.000142	0.00284	CbGeAlD
Valproic Acid—CYP3A4—kidney—type 2 diabetes mellitus	0.000132	0.00265	CbGeAlD
Valproic Acid—SLC22A5—liver—type 2 diabetes mellitus	0.000128	0.00256	CbGeAlD
Valproic Acid—CYP2C8—liver—type 2 diabetes mellitus	0.000124	0.00247	CbGeAlD
Valproic Acid—CYP1A2—liver—type 2 diabetes mellitus	0.000116	0.00232	CbGeAlD
Valproic Acid—CYP3A5—liver—type 2 diabetes mellitus	0.000112	0.00223	CbGeAlD
Valproic Acid—CYP2B6—liver—type 2 diabetes mellitus	0.000111	0.00222	CbGeAlD
Valproic Acid—CYP2C9—liver—type 2 diabetes mellitus	0.00011	0.0022	CbGeAlD
Valproic Acid—CYP3A4—liver—type 2 diabetes mellitus	8.37e-05	0.00168	CbGeAlD
Valproic Acid—Chest pain—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000349	CcSEcCtD
Valproic Acid—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000349	CcSEcCtD
Valproic Acid—Myalgia—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000349	CcSEcCtD
Valproic Acid—Insomnia—Orlistat—type 2 diabetes mellitus	5.15e-05	0.000347	CcSEcCtD
Valproic Acid—Malaise—Losartan—type 2 diabetes mellitus	5.15e-05	0.000347	CcSEcCtD
Valproic Acid—Anxiety—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000347	CcSEcCtD
Valproic Acid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.14e-05	0.000347	CcSEcCtD
Valproic Acid—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.14e-05	0.000347	CcSEcCtD
Valproic Acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.13e-05	0.000347	CcSEcCtD
Valproic Acid—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.13e-05	0.000347	CcSEcCtD
Valproic Acid—Vertigo—Losartan—type 2 diabetes mellitus	5.13e-05	0.000346	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000346	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.000346	CcSEcCtD
Valproic Acid—Somnolence—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000346	CcSEcCtD
Valproic Acid—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.11e-05	0.000345	CcSEcCtD
Valproic Acid—Leukopenia—Losartan—type 2 diabetes mellitus	5.11e-05	0.000345	CcSEcCtD
Valproic Acid—Discomfort—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000344	CcSEcCtD
Valproic Acid—Skin disorder—Metformin—type 2 diabetes mellitus	5.09e-05	0.000344	CcSEcCtD
Valproic Acid—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000343	CcSEcCtD
Valproic Acid—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.07e-05	0.000342	CcSEcCtD
Valproic Acid—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000342	CcSEcCtD
Valproic Acid—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000342	CcSEcCtD
Valproic Acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.05e-05	0.000341	CcSEcCtD
Valproic Acid—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000341	CcSEcCtD
Valproic Acid—Palpitations—Losartan—type 2 diabetes mellitus	5.04e-05	0.00034	CcSEcCtD
Valproic Acid—Nausea—Glimepiride—type 2 diabetes mellitus	5.03e-05	0.000339	CcSEcCtD
Valproic Acid—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000339	CcSEcCtD
Valproic Acid—Nausea—Sitagliptin—type 2 diabetes mellitus	5.01e-05	0.000338	CcSEcCtD
Valproic Acid—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000338	CcSEcCtD
Valproic Acid—Asthenia—Glyburide—type 2 diabetes mellitus	5.01e-05	0.000338	CcSEcCtD
Valproic Acid—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.01e-05	0.000338	CcSEcCtD
Valproic Acid—Anorexia—Metformin—type 2 diabetes mellitus	5e-05	0.000337	CcSEcCtD
Valproic Acid—Cough—Losartan—type 2 diabetes mellitus	4.98e-05	0.000336	CcSEcCtD
Valproic Acid—Urticaria—Gliclazide—type 2 diabetes mellitus	4.98e-05	0.000336	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.97e-05	0.000336	CcSEcCtD
Valproic Acid—Alopecia—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000335	CcSEcCtD
Valproic Acid—Fatigue—Valsartan—type 2 diabetes mellitus	4.96e-05	0.000335	CcSEcCtD
Valproic Acid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.95e-05	0.000335	CcSEcCtD
Valproic Acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.95e-05	0.000335	CcSEcCtD
Valproic Acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000334	CcSEcCtD
Valproic Acid—Oedema—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000334	CcSEcCtD
Valproic Acid—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.95e-05	0.000334	CcSEcCtD
Valproic Acid—Pruritus—Glyburide—type 2 diabetes mellitus	4.94e-05	0.000333	CcSEcCtD
Valproic Acid—Mental disorder—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000332	CcSEcCtD
Valproic Acid—Constipation—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000332	CcSEcCtD
Valproic Acid—Infection—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000332	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.91e-05	0.000332	CcSEcCtD
Valproic Acid—Fatigue—Orlistat—type 2 diabetes mellitus	4.91e-05	0.000331	CcSEcCtD
Valproic Acid—Hypotension—Metformin—type 2 diabetes mellitus	4.9e-05	0.000331	CcSEcCtD
Valproic Acid—Malnutrition—Ramipril—type 2 diabetes mellitus	4.89e-05	0.00033	CcSEcCtD
Valproic Acid—Pain—Orlistat—type 2 diabetes mellitus	4.87e-05	0.000329	CcSEcCtD
Valproic Acid—Chest pain—Losartan—type 2 diabetes mellitus	4.86e-05	0.000328	CcSEcCtD
Valproic Acid—Arthralgia—Losartan—type 2 diabetes mellitus	4.86e-05	0.000328	CcSEcCtD
Valproic Acid—Myalgia—Losartan—type 2 diabetes mellitus	4.86e-05	0.000328	CcSEcCtD
Valproic Acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.85e-05	0.000328	CcSEcCtD
Valproic Acid—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000328	CcSEcCtD
Valproic Acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000327	CcSEcCtD
Valproic Acid—Anxiety—Losartan—type 2 diabetes mellitus	4.84e-05	0.000327	CcSEcCtD
Valproic Acid—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000326	CcSEcCtD
Valproic Acid—Rash—Bromocriptine—type 2 diabetes mellitus	4.81e-05	0.000325	CcSEcCtD
Valproic Acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.81e-05	0.000325	CcSEcCtD
Valproic Acid—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000325	CcSEcCtD
Valproic Acid—Tension—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000324	CcSEcCtD
Valproic Acid—Discomfort—Losartan—type 2 diabetes mellitus	4.8e-05	0.000324	CcSEcCtD
Valproic Acid—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000324	CcSEcCtD
Valproic Acid—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000323	CcSEcCtD
Valproic Acid—Headache—Bromocriptine—type 2 diabetes mellitus	4.78e-05	0.000323	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.78e-05	0.000323	CcSEcCtD
Valproic Acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.78e-05	0.000322	CcSEcCtD
Valproic Acid—Nervousness—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000321	CcSEcCtD
Valproic Acid—Dry mouth—Losartan—type 2 diabetes mellitus	4.75e-05	0.000321	CcSEcCtD
Valproic Acid—Anorexia—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000318	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000318	CcSEcCtD
Valproic Acid—Paraesthesia—Metformin—type 2 diabetes mellitus	4.71e-05	0.000318	CcSEcCtD
Valproic Acid—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000318	CcSEcCtD
Valproic Acid—Confusional state—Losartan—type 2 diabetes mellitus	4.7e-05	0.000317	CcSEcCtD
Valproic Acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.69e-05	0.000317	CcSEcCtD
Valproic Acid—Dyspnoea—Metformin—type 2 diabetes mellitus	4.68e-05	0.000316	CcSEcCtD
Valproic Acid—Somnolence—Metformin—type 2 diabetes mellitus	4.66e-05	0.000315	CcSEcCtD
Valproic Acid—Oedema—Losartan—type 2 diabetes mellitus	4.66e-05	0.000314	CcSEcCtD
Valproic Acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.66e-05	0.000314	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000314	CcSEcCtD
Valproic Acid—Infection—Losartan—type 2 diabetes mellitus	4.63e-05	0.000312	CcSEcCtD
Valproic Acid—Hypotension—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.000312	CcSEcCtD
Valproic Acid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.62e-05	0.000312	CcSEcCtD
Valproic Acid—Dyspepsia—Metformin—type 2 diabetes mellitus	4.62e-05	0.000312	CcSEcCtD
Valproic Acid—Tremor—Ramipril—type 2 diabetes mellitus	4.58e-05	0.00031	CcSEcCtD
Valproic Acid—Urticaria—Valsartan—type 2 diabetes mellitus	4.57e-05	0.000309	CcSEcCtD
Valproic Acid—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.57e-05	0.000308	CcSEcCtD
Valproic Acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.56e-05	0.000308	CcSEcCtD
Valproic Acid—Decreased appetite—Metformin—type 2 diabetes mellitus	4.56e-05	0.000308	CcSEcCtD
Valproic Acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000307	CcSEcCtD
Valproic Acid—Tachycardia—Losartan—type 2 diabetes mellitus	4.55e-05	0.000307	CcSEcCtD
Valproic Acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000307	CcSEcCtD
Valproic Acid—Nausea—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.000306	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.53e-05	0.000306	CcSEcCtD
Valproic Acid—Fatigue—Metformin—type 2 diabetes mellitus	4.52e-05	0.000305	CcSEcCtD
Valproic Acid—Urticaria—Orlistat—type 2 diabetes mellitus	4.52e-05	0.000305	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000304	CcSEcCtD
Valproic Acid—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Valproic Acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Valproic Acid—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Valproic Acid—Asthenia—Gliclazide—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Valproic Acid—Agitation—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Valproic Acid—Constipation—Metformin—type 2 diabetes mellitus	4.48e-05	0.000303	CcSEcCtD
Valproic Acid—Angioedema—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000302	CcSEcCtD
Valproic Acid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.0003	CcSEcCtD
Valproic Acid—Anorexia—Losartan—type 2 diabetes mellitus	4.44e-05	0.0003	CcSEcCtD
Valproic Acid—Vomiting—Glyburide—type 2 diabetes mellitus	4.44e-05	0.0003	CcSEcCtD
Valproic Acid—Pruritus—Gliclazide—type 2 diabetes mellitus	4.43e-05	0.000299	CcSEcCtD
Valproic Acid—Malaise—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000298	CcSEcCtD
Valproic Acid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.41e-05	0.000298	CcSEcCtD
Valproic Acid—Rash—Glyburide—type 2 diabetes mellitus	4.4e-05	0.000297	CcSEcCtD
Valproic Acid—Somnolence—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000297	CcSEcCtD
Valproic Acid—Dermatitis—Glyburide—type 2 diabetes mellitus	4.4e-05	0.000297	CcSEcCtD
Valproic Acid—Vertigo—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000297	CcSEcCtD
Valproic Acid—Leukopenia—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000296	CcSEcCtD
Valproic Acid—Headache—Glyburide—type 2 diabetes mellitus	4.37e-05	0.000295	CcSEcCtD
Valproic Acid—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000294	CcSEcCtD
Valproic Acid—Hypotension—Losartan—type 2 diabetes mellitus	4.35e-05	0.000294	CcSEcCtD
Valproic Acid—Palpitations—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000292	CcSEcCtD
Valproic Acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.32e-05	0.000292	CcSEcCtD
Valproic Acid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.00029	CcSEcCtD
Valproic Acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.00029	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.29e-05	0.00029	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000288	CcSEcCtD
Valproic Acid—Cough—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000288	CcSEcCtD
Valproic Acid—Fatigue—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000288	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.24e-05	0.000286	CcSEcCtD
Valproic Acid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000286	CcSEcCtD
Valproic Acid—Constipation—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000286	CcSEcCtD
Valproic Acid—Pain—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000286	CcSEcCtD
Valproic Acid—Insomnia—Losartan—type 2 diabetes mellitus	4.21e-05	0.000284	CcSEcCtD
Valproic Acid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000283	CcSEcCtD
Valproic Acid—Paraesthesia—Losartan—type 2 diabetes mellitus	4.18e-05	0.000282	CcSEcCtD
Valproic Acid—Urticaria—Metformin—type 2 diabetes mellitus	4.17e-05	0.000281	CcSEcCtD
Valproic Acid—Myalgia—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000281	CcSEcCtD
Valproic Acid—Arthralgia—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000281	CcSEcCtD
Valproic Acid—Chest pain—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000281	CcSEcCtD
Valproic Acid—Dyspnoea—Losartan—type 2 diabetes mellitus	4.15e-05	0.00028	CcSEcCtD
Valproic Acid—Anxiety—Ramipril—type 2 diabetes mellitus	4.15e-05	0.00028	CcSEcCtD
Valproic Acid—Nausea—Glyburide—type 2 diabetes mellitus	4.15e-05	0.00028	CcSEcCtD
Valproic Acid—Abdominal pain—Metformin—type 2 diabetes mellitus	4.15e-05	0.00028	CcSEcCtD
Valproic Acid—Dizziness—Gliclazide—type 2 diabetes mellitus	4.14e-05	0.00028	CcSEcCtD
Valproic Acid—Somnolence—Losartan—type 2 diabetes mellitus	4.14e-05	0.00028	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000279	CcSEcCtD
Valproic Acid—Asthenia—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000279	CcSEcCtD
Valproic Acid—Discomfort—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000278	CcSEcCtD
Valproic Acid—Dyspepsia—Losartan—type 2 diabetes mellitus	4.1e-05	0.000277	CcSEcCtD
Valproic Acid—Asthenia—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000276	CcSEcCtD
Valproic Acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000275	CcSEcCtD
Valproic Acid—Pruritus—Valsartan—type 2 diabetes mellitus	4.07e-05	0.000275	CcSEcCtD
Valproic Acid—Dry mouth—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000275	CcSEcCtD
Valproic Acid—Decreased appetite—Losartan—type 2 diabetes mellitus	4.05e-05	0.000273	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000273	CcSEcCtD
Valproic Acid—Confusional state—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000272	CcSEcCtD
Valproic Acid—Pruritus—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000272	CcSEcCtD
Valproic Acid—Fatigue—Losartan—type 2 diabetes mellitus	4.02e-05	0.000271	CcSEcCtD
Valproic Acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.99e-05	0.00027	CcSEcCtD
Valproic Acid—Oedema—Ramipril—type 2 diabetes mellitus	3.99e-05	0.00027	CcSEcCtD
Valproic Acid—Vomiting—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000269	CcSEcCtD
Valproic Acid—Constipation—Losartan—type 2 diabetes mellitus	3.98e-05	0.000269	CcSEcCtD
Valproic Acid—Pain—Losartan—type 2 diabetes mellitus	3.98e-05	0.000269	CcSEcCtD
Valproic Acid—Rash—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.000267	CcSEcCtD
Valproic Acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.000267	CcSEcCtD
Valproic Acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.94e-05	0.000266	CcSEcCtD
Valproic Acid—Urticaria—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000265	CcSEcCtD
Valproic Acid—Headache—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000265	CcSEcCtD
Valproic Acid—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000264	CcSEcCtD
Valproic Acid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000264	CcSEcCtD
Valproic Acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000264	CcSEcCtD
Valproic Acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000264	CcSEcCtD
Valproic Acid—Tachycardia—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000263	CcSEcCtD
Valproic Acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000263	CcSEcCtD
Valproic Acid—Skin disorder—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000262	CcSEcCtD
Valproic Acid—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000261	CcSEcCtD
Valproic Acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.84e-05	0.000259	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.81e-05	0.000257	CcSEcCtD
Valproic Acid—Dizziness—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000257	CcSEcCtD
Valproic Acid—Anorexia—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000257	CcSEcCtD
Valproic Acid—Dizziness—Orlistat—type 2 diabetes mellitus	3.76e-05	0.000254	CcSEcCtD
Valproic Acid—Asthenia—Metformin—type 2 diabetes mellitus	3.76e-05	0.000254	CcSEcCtD
Valproic Acid—Hypotension—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000252	CcSEcCtD
Valproic Acid—Nausea—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000251	CcSEcCtD
Valproic Acid—Pruritus—Metformin—type 2 diabetes mellitus	3.71e-05	0.00025	CcSEcCtD
Valproic Acid—Urticaria—Losartan—type 2 diabetes mellitus	3.7e-05	0.00025	CcSEcCtD
Valproic Acid—Abdominal pain—Losartan—type 2 diabetes mellitus	3.68e-05	0.000249	CcSEcCtD
Valproic Acid—Body temperature increased—Losartan—type 2 diabetes mellitus	3.68e-05	0.000249	CcSEcCtD
Valproic Acid—Vomiting—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000247	CcSEcCtD
Valproic Acid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000246	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000246	CcSEcCtD
Valproic Acid—Rash—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000245	CcSEcCtD
Valproic Acid—Dermatitis—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000245	CcSEcCtD
Valproic Acid—Vomiting—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000244	CcSEcCtD
Valproic Acid—Insomnia—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000244	CcSEcCtD
Valproic Acid—Headache—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000244	CcSEcCtD
Valproic Acid—Diarrhoea—Metformin—type 2 diabetes mellitus	3.59e-05	0.000242	CcSEcCtD
Valproic Acid—Rash—Orlistat—type 2 diabetes mellitus	3.59e-05	0.000242	CcSEcCtD
Valproic Acid—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000242	CcSEcCtD
Valproic Acid—Dermatitis—Orlistat—type 2 diabetes mellitus	3.58e-05	0.000242	CcSEcCtD
Valproic Acid—Headache—Orlistat—type 2 diabetes mellitus	3.56e-05	0.000241	CcSEcCtD
Valproic Acid—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.56e-05	0.00024	CcSEcCtD
Valproic Acid—Asthenia—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.00024	CcSEcCtD
Valproic Acid—Somnolence—Ramipril—type 2 diabetes mellitus	3.55e-05	0.00024	CcSEcCtD
Valproic Acid—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000237	CcSEcCtD
Valproic Acid—Pruritus—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000236	CcSEcCtD
Valproic Acid—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000234	CcSEcCtD
Valproic Acid—Dizziness—Metformin—type 2 diabetes mellitus	3.47e-05	0.000234	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000233	CcSEcCtD
Valproic Acid—Fatigue—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000232	CcSEcCtD
Valproic Acid—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.43e-05	0.000232	CcSEcCtD
Valproic Acid—Nausea—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000231	CcSEcCtD
Valproic Acid—Constipation—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000231	CcSEcCtD
Valproic Acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000229	CcSEcCtD
Valproic Acid—Nausea—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000228	CcSEcCtD
Valproic Acid—Asthenia—Losartan—type 2 diabetes mellitus	3.34e-05	0.000226	CcSEcCtD
Valproic Acid—Vomiting—Metformin—type 2 diabetes mellitus	3.33e-05	0.000225	CcSEcCtD
Valproic Acid—Rash—Metformin—type 2 diabetes mellitus	3.31e-05	0.000223	CcSEcCtD
Valproic Acid—Dermatitis—Metformin—type 2 diabetes mellitus	3.3e-05	0.000223	CcSEcCtD
Valproic Acid—Pruritus—Losartan—type 2 diabetes mellitus	3.3e-05	0.000222	CcSEcCtD
Valproic Acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000222	CcSEcCtD
Valproic Acid—Headache—Metformin—type 2 diabetes mellitus	3.29e-05	0.000222	CcSEcCtD
Valproic Acid—Dizziness—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000221	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.27e-05	0.00022	CcSEcCtD
Valproic Acid—Diarrhoea—Losartan—type 2 diabetes mellitus	3.19e-05	0.000215	CcSEcCtD
Valproic Acid—Urticaria—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000214	CcSEcCtD
Valproic Acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000213	CcSEcCtD
Valproic Acid—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000213	CcSEcCtD
Valproic Acid—Vomiting—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000212	CcSEcCtD
Valproic Acid—Rash—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000211	CcSEcCtD
Valproic Acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.00021	CcSEcCtD
Valproic Acid—Nausea—Metformin—type 2 diabetes mellitus	3.11e-05	0.00021	CcSEcCtD
Valproic Acid—Headache—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000209	CcSEcCtD
Valproic Acid—Dizziness—Losartan—type 2 diabetes mellitus	3.08e-05	0.000208	CcSEcCtD
Valproic Acid—Vomiting—Losartan—type 2 diabetes mellitus	2.96e-05	0.0002	CcSEcCtD
Valproic Acid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000199	CcSEcCtD
Valproic Acid—Nausea—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000198	CcSEcCtD
Valproic Acid—Rash—Losartan—type 2 diabetes mellitus	2.94e-05	0.000198	CcSEcCtD
Valproic Acid—Dermatitis—Losartan—type 2 diabetes mellitus	2.93e-05	0.000198	CcSEcCtD
Valproic Acid—Headache—Losartan—type 2 diabetes mellitus	2.92e-05	0.000197	CcSEcCtD
Valproic Acid—Asthenia—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000193	CcSEcCtD
Valproic Acid—Pruritus—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000191	CcSEcCtD
Valproic Acid—Nausea—Losartan—type 2 diabetes mellitus	2.77e-05	0.000187	CcSEcCtD
Valproic Acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000184	CcSEcCtD
Valproic Acid—Dizziness—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000178	CcSEcCtD
Valproic Acid—Vomiting—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000171	CcSEcCtD
Valproic Acid—Rash—Ramipril—type 2 diabetes mellitus	2.52e-05	0.00017	CcSEcCtD
Valproic Acid—Dermatitis—Ramipril—type 2 diabetes mellitus	2.52e-05	0.00017	CcSEcCtD
Valproic Acid—Headache—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000169	CcSEcCtD
Valproic Acid—Nausea—Ramipril—type 2 diabetes mellitus	2.37e-05	0.00016	CcSEcCtD
Valproic Acid—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.76e-06	1.67e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	1.76e-06	1.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	1.76e-06	1.66e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	1.76e-06	1.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.75e-06	1.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.75e-06	1.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.75e-06	1.65e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.75e-06	1.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.73e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.73e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.73e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.73e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	1.72e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	1.72e-06	1.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-06	1.62e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	1.71e-06	1.62e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.7e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.69e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.69e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.69e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.69e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.69e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.68e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.67e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.67e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	1.67e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.67e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.67e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	1.65e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.65e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.65e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.64e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	1.63e-06	1.54e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	1.62e-06	1.53e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.62e-06	1.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.61e-06	1.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.6e-06	1.51e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	1.6e-06	1.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.6e-06	1.51e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.6e-06	1.51e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	1.59e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	1.58e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.58e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.58e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.56e-06	1.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.56e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.56e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.56e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	1.55e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.55e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	1.54e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—type 2 diabetes mellitus	1.54e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.53e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—type 2 diabetes mellitus	1.53e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.52e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.52e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	1.51e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	1.51e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.5e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.5e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.49e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.49e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.48e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	1.48e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.48e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.47e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	1.47e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.45e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.43e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.43e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.43e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.43e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—type 2 diabetes mellitus	1.42e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.41e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.4e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.4e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-06	1.31e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.38e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.38e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.37e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.37e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.37e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.36e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.36e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.36e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.36e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.35e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.35e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.35e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.35e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.34e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.34e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.34e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.34e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.31e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.3e-06	1.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.3e-06	1.23e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.29e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.29e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	1.29e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.28e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.28e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.26e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.26e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.24e-06	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-06	1.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.21e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	1.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.18e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.18e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.17e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.16e-06	1.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	1.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.14e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.14e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.09e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.09e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.09e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.06e-06	1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.06e-06	1e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	9.99e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.04e-06	9.86e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.04e-06	9.85e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-06	9.85e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.04e-06	9.82e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-06	9.8e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.03e-06	9.77e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	9.77e-06	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	9.71e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-06	9.71e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	9.55e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.01e-06	9.51e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1e-06	9.45e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.95e-07	9.4e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	9.94e-07	9.38e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.92e-07	9.37e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	9.74e-07	9.2e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	9.57e-07	9.04e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	9.57e-07	9.04e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	9.55e-07	9.02e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	9.37e-07	8.85e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	9.07e-07	8.57e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	9.06e-07	8.56e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8.99e-07	8.49e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.99e-07	8.49e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	8.95e-07	8.45e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	8.93e-07	8.44e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	8.92e-07	8.42e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	8.89e-07	8.39e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	8.88e-07	8.39e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.83e-07	8.34e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	8.79e-07	8.3e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	8.76e-07	8.27e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	8.57e-07	8.09e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	8.55e-07	8.07e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	8.55e-07	8.07e-06	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	8.36e-07	7.89e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.34e-07	7.87e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.18e-07	7.73e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	8.15e-07	7.69e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.01e-07	7.57e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.98e-07	7.54e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	7.82e-07	7.38e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	7.79e-07	7.36e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.79e-07	7.36e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.77e-07	7.34e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	7.74e-07	7.31e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.68e-07	7.25e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	7.59e-07	7.17e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.37e-07	6.96e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.23e-07	6.83e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	7.13e-07	6.73e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7e-07	6.61e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	6.96e-07	6.57e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.88e-07	6.5e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.86e-07	6.48e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	6.81e-07	6.43e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.78e-07	6.4e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	6.66e-07	6.29e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.66e-07	6.29e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	6.44e-07	6.08e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.09e-07	5.75e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.97e-07	5.64e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.86e-07	5.53e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.37e-07	5.07e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	5.2e-07	4.91e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.14e-07	4.85e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.14e-07	4.85e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	5.08e-07	4.8e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.7e-07	4.44e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	4.4e-07	4.16e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.93e-07	3.71e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.58e-07	3.38e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.06e-07	2.89e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.36e-07	2.23e-06	CbGpPWpGaD
